JPRN-UMIN000012389已完成2 期
Phase 2 study of pretreatment with hydroxyurea prior to induction therapy for patients with newly diagnosed acute myeloid leukemia (PREFACE study) - Phase 2 study of pretreatment with hydroxyurea for newly diagnosed AM
Fujita Health University School of Medicine0 个研究点目标入组 26 人开始时间: 2013年11月25日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 26
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Past history of allergy to hydroxyurea; 2) Pregnant and/or lactating woman; 3) Serious mental disorder
研究者
相似试验
招募中
不适用
Evaluation of the efficacy of Hydroxyurea administration on blood oxygen saturation of COVID-19 patientsCOVID-19.COVID-19, virus identifiedU07.1IRCT20210901052358N2Shahid Beheshti University of Medical Sciences10
招募中
2 期
An assessment of effect of pre operative Proluton in patients with operable breast cancerCTRI/2014/11/005229Tata Memorial Centre100
已完成
1 期
Phase I/II trial of oral hydroxyurea in combination with pegylated interferon and ribavirin in chronic hepatitis C patientsChronic hepatitis CJPRN-UMIN000003457Yokohama City University Medical Center Gastroenterological Center20
已完成
不适用
Effect of Hyoscine and Atropine on blood pressure ,heart rate in patient who treated by ECTCondition 1: Schizophrenia. Condition 2: Persistant delusional disorders. Condition 3: Acute and transient psychotic disorder. Condition 4: Manic disorder. Condition 5: Bipolar mood diorder. Condition 6: Depressive episode. Condition 7: Paranoid personality disorder.Persistant delusional disorderManic episodeBipolar affective disorderDepressive episodeSchizophreniaAcute and transient psychotic disorderParanoid personality disorderIRCT2014100719431N1Iran University of Medical Science60
进行中（未招募）
1 期
Phase II study of pre-operative treatment with external radiotherapy plus panitumumab in operable locally advanced rectal cancer (favourable and intermediate prognostic group) (RaP Study/STAR-03)Operable locally advanced rectal cancerMedDRA version: 14.1Level: LLTClassification code 10038019Term: Rectal adenocarcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2011-000649-20-ITFONDAZIONE DELL'ISTITUTO TOSCANO TUMORI92